Patents by Inventor Agung Heru KARSONO

Agung Heru KARSONO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10688146
    Abstract: A preparation comprises a herbal extract and/or fraction, and a pharmaceutical preparation includes extract of Curcuma mangga Val. et Zipp., which has bioactivities in reducing expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The use of this present invention is directed to reduce prostate enlargement. Moreover, it also can be used to treat prostate cancer, lung cancer, and other diseases related to GPCR pathway.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: June 23, 2020
    Assignee: PT Dexa Medica
    Inventors: Asep Aripin, Agung Heru Karsono, Olivia Mayasari, Priska Hardadi, James M. Sinambela, Raymond R. Tjandrawinata
  • Publication number: 20180264070
    Abstract: A preparation comprises a herbal extract and/or fraction, and a pharmaceutical preparation includes extract of Curcuma mangga Val. et Zipp., which has bioactivities in reducing expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The use of this present invention is directed to reduce prostate enlargement. Moreover, it also can be used to treat prostate cancer, lung cancer, and other diseases related to GPCR pathway.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 20, 2018
    Applicant: PT DEXA MEDICA
    Inventors: Asep Aripin, Agung Heru Karsono, Olivia Mayasari, Priska Hardadi, James M. SINAMBELA, Raymond R. TJANDRAWINATA
  • Publication number: 20160143982
    Abstract: A preparation comprises a herbal extract and/or fraction, and a pharmaceutical preparation includes extract of Curcuma mangga Val. et Zipp., which has bioactivities in reducing expression levels of 5-alpha-reductase-1, androgen receptor, and PI3 in prostate cancer cells. The use of this present invention is directed to reduce prostate enlargement. Moreover, it also can be used to treat prostate cancer, lung cancer, and other diseases related to GPCR pathway.
    Type: Application
    Filed: June 3, 2014
    Publication date: May 26, 2016
    Inventors: Asep ARIPIN, Agung Heru KARSONO, Olivia MAYASARI, Prika HARDADI, James M. AMBELA, James M. SINAMBELA